Our technically qualified team of patent and trade mark attorneys has extensive experience in assisting chemical and healthcare companies in all aspects of their IP portfolios in marketplaces across the Asia-Pacific. Our ability to deliver high quality IP services to the chemical and healthcare sectors is enhanced by our Chemical / Life Sciences patent team comprised of scientists trained in a broad range of relevant technologies including cardiovascular, immunoscience, metabolics, neuroscience, oncology and virology. Their expertise includes patent term extensions, data exclusivity, regulatory approval and all other aspects of advice relating to our client’s core commercial products.
Our trade marks team has a long history of representing chemical and healthcare companies in trade mark matters. Our professionals have a deep understanding of the potential issues of trade mark registration of chemical and healthcare brands across the Asia-Pacific. Our dedicated trade mark searching team has experience in pharmaceutical trade mark searches and regularly conduct direct searches of relevant name and image databases.
Spruson & Ferguson Lawyers regularly advises on a wide variety of matters, from general advertising and promotion regulation to consumer protection law, as well as advice on specific biopharma industry codes of conduct and applicable biopharma legislation. Our patent litigation team has an outstanding reputation in the enforcement of IP rights and has acted in some of the most keenly contested patent cases in Australia.
Kristian Robinson is the Managing Director of Spruson & Ferguson (Asia) and Director of the firm’s Asia-Pacific patent practices. Kristian is based in the Singapore head office of our…
Kristian Robinson is the Managing Director of Spruson & Ferguson (Asia) and Director of the firm’s Asia-Pacific patent practices….
Oliver Lutze is Spruson & Ferguson’s Country Manager for China. He is based in Beijing and advises on patent matters with a special focus on China activities.
Oliver’s practice primarily…
Oliver Lutze is Spruson & Ferguson’s Country Manager for China. He is based in Beijing and advises on patent…
Simon joined Spruson & Ferguson in 2007 and is an experienced patent attorney specialising in the field of biotechnology. He completed a Bachelor degree specialising in molecular biology and…
Simon joined Spruson & Ferguson in 2007 and is an experienced patent attorney specialising in the field of biotechnology….
Following on from our earlier article on patent term extension (PTE) for pharmaceutical substances, three related decisions issued by the Australian Patent Office provide guidance on the requirements and…
Following on from our earlier article on patent term extension (PTE) for pharmaceutical substances, three related decisions issued by…
On 28 August 2018, the Singapore Court of Appeal issued its decision on Cicada Cube Pte Ltd v National University Hospital (Singapore) Pte Ltd SGCA 52. The judgement…
On 28 August 2018, the Singapore Court of Appeal issued its decision on Cicada Cube Pte Ltd v National…
In our newsletter of March 16, 2017 we reported on the recent changes in the Guidelines for Examination http://www.spruson.com/china-revises-guidelines-for-patent-examination/ . In one paragraph we speculated that there is a…
In our newsletter of March 16, 2017 we reported on the recent changes in the Guidelines for Examination http://www.spruson.com/china-revises-guidelines-for-patent-examination/…
Under Australian patent law, the term of a pharmaceutical patent may be extended if certain criteria are met. In this regard, a patent term extension (PTE) of up to…
Under Australian patent law, the term of a pharmaceutical patent may be extended if certain criteria are met. In…
We use cookies to ensure functionality of our website and to enhance your user experience. By entering our site, you acknowledge you have read and accept our Privacy Policy and Disclaimer and are happy to continue on our site with these functional cookies enabled. We also collect anonymised analytics data. By clicking Accept, you acknowledge you are happy to continue on our site with analytics cookies enabled:
